PredictCan is the first individual-centric preclinical platform to reproduce human biological diversity in vitro, enabling a true population-level "trial-in-a-dish" approach to predict drug efficacy, identify toxicity, and understand interindividual variability before clinical trials begin. PredictCan helps answer the questions that truly matter: • Who Will Benefit ? • Who Is At Risk ? • How Do Responses Vary Across Populations ? • Why Do These Differences Occur?
| Website | https://www.predictcan.com/ |
| Employees | 5 (2 on RocketReach) |
| Phone | +33 7 81 83 94 63 |
| Industry | Biotechnology Research |
| Keywords | Cancer Diagnostics, Predictive Oncology, Early Cancer Detection, Precision Oncology, Artificial Intelligence In Medicine, Personalized Medicine, Cancer Research, Ai-Powered Diagnostics, Patient Stratification, Biomarkers, Cell Reprogramming, In Vitro Diagnostics, Clinical Trial Technology, Biotechnology, Medical Technology, Digital Health, Drug Discovery, Therapeutic Drug Monitoring, Healthcare |
Looking for a particular PredictCan Biotechnologies employee's phone or email?
Hong Duong is the CEO of PredictCan Biotechnologies.
2 people are employed at PredictCan Biotechnologies.